Intermittent Claudication
📧 Sign up to get email alerts when something new happens for Intermittent Claudication.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD? [Phase 3]
A Phase 3 trial investigated whether reducing total body iron stores can affect mortality in patients with advanced peripheral vascular dise…
-
CLINICAL_TRIALS trial_result · 2012-06-29Clinical Trial Update: Prostaglandin E1 in Outpatients With Intermittent Claudication [Phase 3]
Phase 3 trial evaluating prostaglandin E1 in outpatients with intermittent claudication due to stage II peripheral arterial occlusive diseas…
-
CLINICAL_TRIALS research · 2012-05-15Clinical Trial Update: Subjective and Objective Methods of Assessing Walking Limitation Due to Claudication
A completed clinical trial update examining subjective and objective methods for measuring walking limitation in intermittent claudication.
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication [Phase 2]
Phase 2 clinical trial of K-134 for intermittent claudication has completed. The study evaluated safety and efficacy of the treatment.
-
FDA approval · 2012-03-09FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Cilostazol, enabling the generic Cilostazol product to be marketed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-09Clinical Trial Update: A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed Conditions [Phase 1]
Phase 1 bioavailability study comparing Pletal 100 mg tablet with a new Pletal 100 mg orodispersible tablet under fasting (with and without …
-
CLINICAL_TRIALS trial_result · 2011-09-09Clinical Trial Update: Trial Comparing Different Medical Devices for Infragenual Dilatation [NA]
Completed clinical trial comparing different medical devices for infragenual dilatation in patients with diabetic angiopathies and intermitt…
-
CLINICAL_TRIALS trial_result · 2011-08-25Clinical Trial Update: Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication) [Phase 3]
Phase 3 trial completed evaluating the safety and efficacy of Propionyl-L-Carnitine for Peripheral Arterial Disease presenting with intermit…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent Claudication [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the safety, efficacy, and pharmacokinetics of Trans Sodium Crocetinate for intermittent clau…
-
CLINICAL_TRIALS research · 2011-07-06Clinical Trial Update: Autologous Bone Marrow-derived Mononuclear Cells for Therapeutic Arteriogenesis in Patients With Limb Ischemia [Phase 2, Phase 3]
Phase 2/Phase 3 clinical trial evaluating autologous bone marrow-derived mononuclear cells to promote therapeutic arteriogenesis in patients…
-
CLINICAL_TRIALS trial_result · 2011-06-09Clinical Trial Update: Caffeine and Intermittent Claudication [Phase 3]
A Phase 3 clinical trial evaluating caffeine for intermittent claudication has completed.
-
CLINICAL_TRIALS trial_result · 2011-03-17Clinical Trial Update: Exercise Training for Patients With Poor Leg Circulation [NA]
This entry notes the completion of a clinical trial evaluating exercise training for patients with type 2 diabetes mellitus and intermittent…
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD) [Phase 2]
A Phase 2 trial evaluating NCX4016 for improving walking distance in peripheral arterial occlusive disease has completed. The study addresse…
-
CLINICAL_TRIALS trial_result · 2010-12-01Clinical Trial Update: DURABILITY-200: EverFlex 200mm Long Nitinol Stents in TASC C&D Femoropopliteal Lesions [Phase 4]
Phase 4 trial update showing completion of the DURABILITY-200 study evaluating EverFlex 200 mm nitinol stents in TASC C&D femoropopliteal le…
-
CLINICAL_TRIALS research · 2010-08-06Clinical Trial Update: Angioplasty or Bypass Surgery in Intermittent Claudication
This item provides an update on a clinical trial comparing angioplasty versus bypass surgery for intermittent claudication due to superficia…
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes [Phase 3]
Phase 3 trial SIMPADICO investigating immune modulation therapy in peripheral arterial disease and intermittent claudication was terminated.
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD) [Phase 2]
This document provides a Phase 2 clinical trial update for FM220 in patients with peripheral arterial disease and intermittent claudication;…
-
CLINICAL_TRIALS research · 2009-11-04Clinical Trial Update: Treatment of Claudication With a Peristaltic Pulse Pneumatic Device [Phase 2]
Update on a Phase 2 clinical trial evaluating a peristaltic pulse pneumatic device for treating intermittent claudication.
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Whole Body Magnetic Resonance Angiography in Ischemic Patients at 1.5 and 3T
A clinical trial evaluating whole-body magnetic resonance angiography in patients with atherosclerosis and intermittent claudication has bee…
-
CLINICAL_TRIALS research · 2009-08-19Clinical Trial Update: Patient Acceptance of Whole Body Magnetic Resonance Angiography
Clinical trial update describing patient acceptance of whole-body MR angiography in participants with atherosclerosis and intermittent claud…
-
CLINICAL_TRIALS trial_result · 2009-08-19Clinical Trial Update: Whole Body Magnetic Resonance Angiography With Subsystolic Venous Compression
A completed clinical trial evaluating whole-body magnetic resonance angiography to assess subsystolic venous compression. The study focused …
-
CLINICAL_TRIALS trial_result · 2009-07-27Clinical Trial Update: Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication
A completed University of Sao Paulo clinical trial reports on the prevalence of metabolic syndrome among patients with intermittent claudica…
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Whole-Body MRA at 3T - A Comparison Between Two Different Scan Protocols
This completed clinical trial update compares two whole-body MRA scan protocols at 3 Tesla to assess imaging performance in vascular disease…
-
CLINICAL_TRIALS trial_result · 2008-12-19Clinical Trial Update: Mixed Antagonist of Serotonin for Claudication Optimal Therapy [Phase 2]
This update notes the completion of a Phase 2 study evaluating a mixed antagonist of serotonin for intermittent claudication, with no result…
-
FDA approval · 2008-08-29FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Cilostazol from Apotex Corp., authorizing the marketing of a generic cilostazol product.